[Acute myocardial infarction in the elderly: increased incidence of atypical presentations].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 3817614)

Published in Harefuah on November 16, 1986

Authors

O Sofer, M Fainaru

Articles by these authors

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet (2000) 6.19

Behçet's disease. Report of 41 cases and a review of the literature. Medicine (Baltimore) (1975) 5.68

Parents as the exclusive agents of change in the treatment of childhood obesity. Am J Clin Nutr (1998) 2.49

Structural and metabolic heterogeneity of beta-very low density lipoproteins from cholesterol-fed dogs and from humans with type III hyperlipoproteinemia. J Lipid Res (1982) 1.57

Composition of proteins of mesenteric lymph chylomicrons in the rat and alterations produced upon exposure of chylomicrons to blood serum and serum proteins. J Lipid Res (1978) 1.48

The removal of cholesterol from aortic smooth muscle cells in culture and Landschutz ascites cells by fractions of human high-density apolipoprotein. Biochim Biophys Acta (1975) 1.46

Transient normal platelet counts and decreased requirement for interferon during pregnancy in essential thrombocythaemia. Br J Haematol (1996) 1.39

Radioimmunoassay of arginine-rich apolipoprotein of rat serum. Biochim Biophys Acta (1977) 1.32

Role of behaviour modification in the treatment of childhood obesity with the parents as the exclusive agents of change. Int J Obes Relat Metab Disord (1998) 1.27

Visualization of virus-like particles in endoplasmic reticulum of hepatocytes of Australia antigen carriers. Lab Invest (1972) 1.23

Apoprotein content of plasma lipoproteins of the rat separated by gel chromatography or ultracentrifugation. Biochem Med (1977) 1.11

Radioimmunoassay of human high density lipoprotein apo-protein A-1. Biochim Biophys Acta (1975) 1.10

Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment. J Clin Invest (1984) 1.10

Acute promyelocytic leukaemia with t(15;17) following treatment of Hodgkin's disease--a report of 4 cases. Ann Oncol (1995) 1.09

Temporal arteritis in Israel. A review of 47 patients. J Rheumatol (1979) 1.04

Chylomicron-chylomicron remnant clearance by liver and bone marrow in rabbits. Factors that modify tissue-specific uptake. J Biol Chem (1989) 1.04

Radioimmunoassay of apolipoprotein A-I of rat serum. Biochim Biophys Acta (1976) 1.04

Secretion of the arginine-rich and A-I apolipoproteins by the isolated perfused rat liver. J Lipid Res (1977) 1.02

Apoprotein synthesis by human duodenojejunal mucosa. Gastroenterology (1978) 1.01

Origin and transport of the A-I and arginine-rich apolipoproteins in mesenteric lymph of rats. J Lipid Res (1978) 0.98

Behçet's disease with decreased fibrinolysis and superior vena caval occlusion. Br Med J (1973) 0.96

Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis. Kidney Int (1999) 0.93

Evidence that a separate particle containing B-apoprotein is present in high-density lipoproteins from perfused rat liver. Metabolism (1977) 0.91

In vitro production of human plasma low density lipoprotein-like particles. A model for very low density lipoprotein catabolism. J Biol Chem (1979) 0.90

Hypolipidemic effect of beta, beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) in normal and nephrotic rats. J Lipid Res (1988) 0.89

Lipid oxidation in unfractionated serum and plasma. Chem Phys Lipids (1998) 0.89

Insulin resistance in obesity: body-weight or energy balance? J Endocrinol (2001) 0.88

Virus-like particles in cytoplasm of livers of Au-antigen carriers. Lancet (1971) 0.87

Impact of treatment for childhood obesity on parental risk factors for cardiovascular disease. Prev Med (1999) 0.86

Weight gain and insulin resistance during nicotine replacement therapy. Clin Cardiol (1999) 0.86

Effect of weight loss in moderate obesity on plasma lipoprotein and apolipoprotein levels and on high density lipoprotein composition. Arteriosclerosis (1984) 0.86

Transport of vitamin D sterols in human plasma: effect of excess vitamin D, 25 hydroxyvitamin D and 1,25 dihydroxyvitamin D. Eur J Clin Invest (1979) 0.83

Intestinal absorption of vitamin D sterols: differential absorption into lymph and portal blood in the rat. Gastroenterology (1981) 0.83

Kinetics of peritoneal protein loss during CAPD: II. Lipoprotein leakage and its impact on plasma lipid levels. Kidney Int (1990) 0.81

The role of lysophosphatidylcholine and apolipoprotein A in the cholesterol-removing capacity of lipoprotein-deficient serum in tissue culture. Biochim Biophys Acta (1979) 0.81

Regulation of lipoprotein lipase secretion in murine macrophages during foam cell formation in vitro. Effect of triglyceride-rich lipoproteins. Arterioscler Thromb (1992) 0.81

Comparison of hemostatic factors and serum malondialdehyde as predictive factors for cardiovascular disease in hemodialysis patients. Am J Kidney Dis (1999) 0.81

Apolipoprotein A-I synthesis and secretion by cultured human intestinal mucosa. Metabolism (1979) 0.81

Kinetic analysis of copper-induced peroxidation of HDL, autoaccelerated and tocopherol-mediated peroxidation. Free Radic Biol Med (2000) 0.81

Defibrination following Echis colorata bite in man. Isr J Med Sci (1971) 0.81

Inner ear involvement in Behçet's disease. Arch Otolaryngol (1980) 0.80

Single-stage evaluation of serum lipoproteins by gel permeation using a specific fluorescent lipid probe. J Chromatogr (1987) 0.80

Copper-induced lipid oxidation in unfractionated plasma: the lag preceding oxidation as a measure of oxidation-resistance. Biochem Biophys Res Commun (1995) 0.79

Aggregation of plasma lipids and lipoproteins in families with and without coronary heart disease. Atherosclerosis (1985) 0.79

Apolipoproteins in human fetal blood and amniotic fluid in mid-trimester pregnancy. Prenat Diagn (1981) 0.78

Kinetics of peritoneal protein loss during CAPD: I. Different characteristics for low and high molecular weight proteins. Kidney Int (1990) 0.78

Optic nerve regeneration in adult fish and apolipoprotein A-I. J Neurochem (1989) 0.78

Change in very low-, low-, and high-density lipoproteins during lipid lowering (bezafibrate) therapy: studies in type IIA and type IIb hyperlipoproteinaemia. Eur J Clin Invest (1986) 0.78

The effects of prednisone therapy on plasma lipoproteins and apolipoproteins: a prospective study. Metabolism (1984) 0.77

[Alcohol-related admissions in a community hospital]. Harefuah (1990) 0.77

Oxidation of low density lipoprotein upon sequential exposure to copper ions. Free Radic Res (1995) 0.77

Kinetics of lipid peroxidation in mixtures of HDL and LDL, mutual effects. Free Radic Biol Med (2001) 0.77

Correlates of biochemical variables in the Jerusalem Lipid Research Clinic population. Isr J Med Sci (1982) 0.77

Dietary enrichment with alpha-linolenic acid during pregnancy attenuates insulin resistance in adult offspring in mice. Arch Physiol Biochem (2014) 0.77

Basal and post-methionine serum homocysteine and lipoprotein abnormalities in patients with chronic liver disease. J Investig Med (2001) 0.77

A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. Leuk Lymphoma (1995) 0.77

Fish apolipoprotein-A-I has heparin binding activity: implication for nerve regeneration. J Neurochem (1990) 0.77

The effect of albumin on copper-induced LDL oxidation. Biochim Biophys Acta (1997) 0.76

Susceptibility of serum lipids to copper-induced peroxidation correlates with the level of high density lipoprotein cholesterol. Lipids (1999) 0.76

Insulin resistance is increased by transdermal estrogen therapy in postmenopausal women with cardiac syndrome X. Cardiology (2001) 0.76

Vitamin D transport in an infant with vitamin D toxicity. Br Med J (1978) 0.75

Clinical problem-solving: stopping short of certainty. N Engl J Med (1994) 0.75

Heterogeneity in peritoneal transport during continuous ambulatory peritoneal dialysis and its impact on ultrafiltration, loss of macromolecules and plasma level of proteins, lipids and lipoproteins. Nephron (1993) 0.75

Recurrent hepatitis caused by two viruses acquired simultaneously during blood transfusion. Vox Sang (1980) 0.75

Asymptomatic hepatitis B antigen carriers: a clinicopathological study. Acta Hepatogastroenterol (Stuttg) (1974) 0.75

Effect of moderate isocaloric modification of dietary carbohydrate on high-density lipoprotein composition and apolipoprotein A-1 turnover in humans. Isr J Med Sci (1986) 0.75

The removal of cellular lipids from Landschůtz ascites cells and smooth muscle cells in culture. Adv Exp Med Biol (1976) 0.75

A model for educating humanistic physicians in the 21st century: the new medicine, patient, and society course at Tel Aviv University. Educ Health (Abingdon) (2000) 0.75

Lipid binding protein (apolipoprotein A-I) contamination of high grade commercial albumins. FEBS Lett (1979) 0.75

Virus-like particles in the cytoplasm of a patient with acute hepatitis associated with Australia antigen. Isr J Med Sci (1972) 0.75

Molecular basis of the antigenic difference between two closely related lysozymes of known sequence: effect of internal substitutions. Immunochemistry (1974) 0.75

[Weight gain due to anti-psychotic medication]. Harefuah (2000) 0.75

Iatrogenic polydipsia. Lancet (1977) 0.75

The natural course of defibrination syndrome caused by Echis colorata venom in man. Thromb Diath Haemorrh (1974) 0.75

Correlation of structural differences in several bird lysozymes and their loop regions with immunological cross-reactivity. J Mol Biol (1974) 0.75

Australia antigen in Jerusalem. Isr J Med Sci (1972) 0.75

Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabine. Leuk Res (1999) 0.75

Serum and effluent lysozyme (muramidase) activity in CAPD patients. Adv Perit Dial (1989) 0.75

[Cholesterol metabolism and atherosclerosis]. Harefuah (1990) 0.75

[International postgraduate training program in medicine: survey of 13 training courses, 1988-1994]. Harefuah (1995) 0.75

Postremission therapy with two different dose regimens of cytarabine in adults with acute myelogenous leukemia. Leuk Res (1995) 0.75

Distribution of actin, myosin and actin binding protein in platelets of patients with hyperlipoproteinemia. Thromb Res (1983) 0.75

Efficacy and safety of pravastatin once daily in primary moderate hypercholesterolemia: the Israeli experience. Isr J Med Sci (1993) 0.75

The effect of neck dissection on human fat transport. Am J Otolaryngol (2001) 0.75

Virus-like particles in the cytoplasm of the livers of Australia antigen carriers. Am J Dis Child (1972) 0.75

[Acute renal failure as a result of intravenous cholangiography (meglumine iodipamide)]. Harefuah (1978) 0.75

Hexasomy of chromosome 8 and trisomy of chromosome 11 characterize two karyotypically independent clones in a case of acute non-lymphocytic leukemia. Conventional cytogenetic and FISH investigation. Cancer Genet Cytogenet (1995) 0.75

The role of different albumin preparations on production of human plasma lipoprotein-like particles in vitro. J Lipid Res (1980) 0.75

Secretion of lipoproteins, apolipoprotein A-I and apolipoprotein E by isolated and perfused liver of rat with experimental nephrotic syndrome. Biochim Biophys Acta (1981) 0.75

Acute myocardial infarction is associated with increased susceptibility of serum lipids to copper-induced peroxidation in vitro. Clin Cardiol (2002) 0.75

Isolation and characterization of lipid-protein complexes present in commercial albumin preparations. Prep Biochem (1981) 0.75

LDL-associated phospholipase A does not protect LDL against lipid peroxidation in vitro. Free Radic Biol Med (1998) 0.75

The effect of lovastatin on early restenosis. J Clin Pharmacol (1995) 0.75

Analysis of risk factors in 532 survivors of first myocardial infarction hospitalized in Jerusalem. Atherosclerosis (1986) 0.75

A method for studying plasma transport of vitamin D applicable to hypervitaminosis D. Clin Chim Acta (1979) 0.75